Specifically, a reduction in cytokines such as tumor necrosis factor-alpha (TNF-α), interleukin-6 (IL-6), and interleukin-1 beta (IL-1β) can decrease the inflammatory response in the gut, leading to improved intestinal function and reduced discomfort associated with IBS [75]. The gene discussed is IL1B; the disease is irritable bowel syndrome.